Walgreens Boots Alliance, Inc. (NASDAQ:WBA) CFO Manmohan Mahajan Acquires 6,000 Shares of Stock

Walgreens Boots Alliance, Inc. (NASDAQ:WBAGet Free Report) CFO Manmohan Mahajan purchased 6,000 shares of the stock in a transaction dated Tuesday, April 2nd. The shares were purchased at an average price of $19.38 per share, with a total value of $116,280.00. Following the transaction, the chief financial officer now directly owns 166,969 shares of the company’s stock, valued at approximately $3,235,859.22. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Walgreens Boots Alliance Stock Down 4.2 %

WBA stock opened at $18.72 on Wednesday. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.66 and a quick ratio of 0.32. The firm has a market capitalization of $16.14 billion, a P/E ratio of -2.67, a P/E/G ratio of 1.34 and a beta of 0.73. Walgreens Boots Alliance, Inc. has a 52-week low of $18.67 and a 52-week high of $36.58. The company’s 50 day simple moving average is $21.65 and its 200-day simple moving average is $22.26.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last announced its earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.82 by $0.38. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The company had revenue of $37.05 billion for the quarter, compared to the consensus estimate of $35.86 billion. During the same period in the previous year, the business earned $1.16 EPS. The company’s revenue was up 6.3% on a year-over-year basis. As a group, equities research analysts anticipate that Walgreens Boots Alliance, Inc. will post 3.25 EPS for the current year.

Institutional Investors Weigh In On Walgreens Boots Alliance

Institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. lifted its position in shares of Walgreens Boots Alliance by 14.5% in the third quarter. Vanguard Group Inc. now owns 86,675,198 shares of the pharmacy operator’s stock worth $1,927,656,000 after purchasing an additional 10,962,030 shares in the last quarter. Moneta Group Investment Advisors LLC boosted its stake in shares of Walgreens Boots Alliance by 84,503.5% during the 4th quarter. Moneta Group Investment Advisors LLC now owns 8,325,830 shares of the pharmacy operator’s stock valued at $311,053,000 after buying an additional 8,315,989 shares during the period. Capital World Investors grew its holdings in shares of Walgreens Boots Alliance by 29.1% during the 4th quarter. Capital World Investors now owns 18,448,648 shares of the pharmacy operator’s stock valued at $481,694,000 after acquiring an additional 4,163,317 shares in the last quarter. Invesco Ltd. increased its stake in shares of Walgreens Boots Alliance by 21.5% in the third quarter. Invesco Ltd. now owns 17,026,420 shares of the pharmacy operator’s stock worth $378,668,000 after acquiring an additional 3,013,807 shares during the last quarter. Finally, BlackRock Inc. boosted its position in Walgreens Boots Alliance by 4.6% during the first quarter. BlackRock Inc. now owns 63,406,129 shares of the pharmacy operator’s stock valued at $2,192,584,000 after purchasing an additional 2,797,885 shares during the last quarter. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research firms have commented on WBA. SVB Leerink decreased their target price on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a “market perform” rating for the company in a research report on Monday, March 18th. Bank of America decreased their price objective on Walgreens Boots Alliance from $23.00 to $22.00 and set an “underperform” rating for the company in a report on Tuesday, March 26th. Truist Financial reaffirmed a “hold” rating and set a $25.00 target price on shares of Walgreens Boots Alliance in a research note on Monday. Raymond James reissued a “market perform” rating on shares of Walgreens Boots Alliance in a research note on Tuesday, March 26th. Finally, HSBC restated a “reduce” rating and set a $20.00 price objective (down from $27.00) on shares of Walgreens Boots Alliance in a research note on Tuesday, February 20th. Four analysts have rated the stock with a sell rating, nine have issued a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $24.92.

View Our Latest Analysis on WBA

About Walgreens Boots Alliance

(Get Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Featured Stories

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.